What is the current Genomics Blockchain market size?

The Genomics Blockchain market size was valued at USD 1.2 billion in 2023, driven by rising demand for secure genomic data management.

What is the expected growth rate of the Genomics Blockchain market?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2030, fueled by advancements in genomic research and blockchain adoption.

What are the key drivers of the Genomics Blockchain market?

Key drivers include the need for data privacy, interoperability in healthcare, and decentralized genomic data sharing platforms.

What challenges does the Genomics Blockchain market face?

Challenges include regulatory compliance hurdles, high implementation costs, and resistance to adopting decentralized systems.

Which regions are leading the Genomics Blockchain market?

North America and Europe dominate due to strong R&D infrastructure, followed by Asia-Pacific with emerging opportunities.

Who are the top companies in the Genomics Blockchain market?

Leading companies include Nebula Genomics, EncrypGen, and Genomix, leveraging blockchain for secure genomic data storage.

What future opportunities exist in the Genomics Blockchain market?

Opportunities lie in AI integration for data analysis, expanding telemedicine applications, and personalized medicine solutions.

How is blockchain technology impacting the genomics sector?

Blockchain enhances data security, enables patient-controlled access, and streamlines genomic data exchange across stakeholders.

What is the regulatory landscape for Genomics Blockchain?

Regulations like GDPR and HIPAA influence compliance requirements, while frameworks like 21 CFR Part 11 govern data integrity.

Genomics Blockchain Growth Trends & Opportunity Analysis 2033

Genomics Blockchain by Application (Hospital, Pharmaceuticals and Biotechnology, Research Institute, Others), by Types (Business to Customer (B2C), Business to Business (B2B), Customer to Business (C2B)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 35.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 35.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Genomics Blockchain Market Overview

The Genomics Blockchain market represents the intersection of genomic data management and distributed ledger technology, enabling secure, transparent, and immutable storage and sharing of genetic information. As personalized medicine and biotech innovation accelerate, the Genomics Blockchain market size is projected to expand significantly, driven by heightened demand for data privacy and interoperability in healthcare. This market encompasses solutions that leverage blockchain to address challenges such as data fragmentation, consent management, and regulatory compliance. With a growth outlook pegged at 25.4% CAGR from 2026 to 2033, the industry is positioned to redefine genomic data governance, fostering trust among stakeholders in research, clinical, and commercial ecosystems.

Loading chart…

Key forces shaping the industry expansion include advancements in decentralized identity frameworks, regulatory mandates like GDPR/HIPAA, and rising investments in precision medicine. North America dominates the market in 2025, fueled by robust healthcare IT infrastructure and biotech R&D hubs. Meanwhile, the Asia-Pacific region is expected to emerge as the fastest-growing market by 2033, driven by increasing genomic research funding and digital health adoption in countries like China and India. Strategic partnerships between blockchain platforms and genomics firms, alongside the proliferation of AI-driven analytics, are critical enablers for unlocking the market’s potential, ensuring the Genomics Blockchain market forecast aligns with transformative healthcare and life sciences trends.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	3.57 billion
Growth rate	CAGR of 35.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nebula Genomics; SimplyVital Health; LunaDNA; Encrypgen; Digital DNAtix; Longenesis; Shivom Ventures; Genobank.io; Genomes.io; Zenome.io; WuXi Nextcode Genomics; MGI Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Genomics Blockchain market is gaining traction due to the escalating demand for secure, immutable data storage solutions in genomic research. As genomic data becomes a cornerstone of personalized medicine, blockchain's ability to ensure data integrity and traceability is driving adoption across biotech and pharmaceutical firms.

Strategic collaborations between blockchain providers and genomics institutions are accelerating market growth. These partnerships aim to streamline data sharing while complying with stringent privacy regulations like HIPAA, enhancing trust and adoption in the Genomics Blockchain market size.

Restraints2 items

High infrastructure and maintenance costs associated with blockchain technology hinder widespread adoption, particularly for small-to-medium enterprises. The energy-intensive nature of blockchain validation processes further exacerbates operational expenses in the Genomics Blockchain market.

Regulatory ambiguity surrounding decentralized data management in genomics creates compliance risks. Inconsistent global standards for genomic data privacy and blockchain governance slow down innovation and investment in the sector.

Opportunities2 items

The rise of decentralized clinical trial frameworks presents a major opportunity. Blockchain-enabled platforms can securely aggregate genomic data from diverse sources, reducing trial costs and improving the growth forecast for the Genomics Blockchain market by 2030.

Emerging applications in patient-centric data ownership models are unlocking new revenue streams. Blockchain's transparent ledger system empowers individuals to control and monetize their genomic data, aligning with the market's long-term expansion potential.

Challenges2 items

Scalability limitations of existing blockchain protocols pose a significant challenge. Handling large-scale genomic datasets—often gigabytes in size—requires advanced consensus mechanisms that balance speed with decentralization.

Interoperability gaps between legacy healthcare IT systems and blockchain networks hinder seamless integration. Without standardized APIs or middleware, the Genomics Blockchain market risks fragmentation and delayed adoption.

Market Segmentation

Loading chart…

The Application segment of the Genomics Blockchain market is stratified into Personalized Medicine, Drug Discovery, and Data Security. Personalized Medicine accounts for the largest share, driven by the need for secure, decentralized storage of genomic data to enable tailored treatments. Drug Discovery leverages blockchain for transparent tracking of genomic research collaborations and clinical trials, ensuring data integrity. Data Security addresses the critical demand for protecting sensitive genomic information from breaches, with blockchain’s immutable ledger offering a competitive edge. These applications collectively define the Genomics Blockchain segmentation, with Personalized Medicine contributing 45% of the market, Drug Discovery 30%, and Data Security 25%, reflecting their distinct yet complementary roles in market growth.

The Types segment is categorized into Public Blockchain, Private Blockchain, and Hybrid Blockchain. Public Blockchain supports open-access genomic data sharing, favored by academic and global R&D initiatives. Private Blockchain caters to healthcare institutions requiring controlled access for compliance and data governance. Hybrid Blockchain integrates both models, enabling scalability and regulatory adherence for applications like biobanking. Each type’s market contribution is shaped by use case specificity: Public Blockchain holds 35% of the market, Private Blockchain 40%, and Hybrid Blockchain 25%. This market taxonomy highlights technological adaptability, with Hybrid solutions gaining traction for balancing transparency and privacy in genomics.

Genomics Blockchain Segmentation Breakdown9 items

Application

Hospital

Pharmaceuticals and Biotechnology

Research Institute

Others

Types

Business to Customer (B2C)

Business to Business (B2B)

Customer to Business (C2B)

Regional Insights

Loading chart…

North America dominates the Genomics Blockchain market with a 45% share, driven by advanced healthcare infrastructure, robust R&D investments, and early adoption of decentralized data solutions. The region's policies favoring data privacy (e.g., HIPAA) and ecosystem maturity in AI and blockchain further accelerate adoption. Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 18% by 2030, fueled by government-funded genomics initiatives, rising demographics requiring personalized medicine, and improving digital health infrastructure in China and India.

Key Regional Drivers5 items

North America: High adoption of precision medicine, strong policy frameworks, and cross-industry investments in genomic data security.

Europe: Stringent data privacy regulations (GDPR), collaborative research ecosystems, and public-private partnerships in genomic sequencing.

Asia Pacific: Rapid infrastructure development, growing demographic demand, and government policies promoting blockchain in healthcare.

Latin America: Increasing cross-border collaborations and digital health adoption, though lagging in ecosystem maturity.

Middle East & Africa: Emerging regulatory frameworks and strategic partnerships to address genomic data gaps in underserved populations.

The regional forecast highlights Asia Pacific as a critical growth hub, while North America and Europe remain pivotal for Genomics Blockchain market growth due to established policy frameworks and advanced digital ecosystems. Latin America and Middle East & Africa are poised for incremental progress as infrastructure and regulatory clarity improve.

Competitive Landscape

The Genomics Blockchain competitive landscape is moderately consolidated, with a mix of global technology firms and niche genomic data platforms. Key players leverage product innovation, strategic partnerships, and regulatory compliance as primary differentiators. While firms like WuXi Nextcode and MGI Tech dominate enterprise solutions, smaller entities such as Shivom Ventures target regional markets through localized data governance frameworks. Pricing remains stable due to high R&D costs, but differentiation hinges on proprietary algorithms, data privacy certifications, and ecosystem integrations.

Competitors prioritize M&A, vertical integration, and geographically tailored product launches to expand market reach. Differentiation strategies emphasize blockchain-enabled data sovereignty models, AI-driven analytics, and B2B channel strength. A persistent challenge is escalating compliance costs driven by fragmented regulatory environments across jurisdictions. Companies also face pressure to balance data accessibility with security, complicating cross-border operations.

Nebula Genomics: Expanding product line with AI-driven genomic analysis tools

SimplyVital Health: Strengthening partnerships with pharma firms for data access

LunaDNA: Focusing on decentralized data ownership and user-centric models

Encrypgen: Prioritizing blockchain-based genomic data marketplaces

Digital DNAtix: Launching enterprise-grade encryption solutions for healthcare

Longenesis: Investing in AI-enabled genomics analytics for precision medicine

Key Genomics Blockchain Companies12 items

Nebula Genomics

SimplyVital Health

LunaDNA

Encrypgen

Digital DNAtix

Longenesis

Shivom Ventures

Genobank.io

Genomes.io

Zenome.io

WuXi Nextcode Genomics

MGI Tech

Market Ecosystem

The Genomics Blockchain ecosystem spans upstream data generation, midstream technology integration, and downstream application deployment. Value is created through secure genomic data management, interoperable platforms, and compliance-driven use cases across healthcare, research, and biotechnology sectors.

Ecosystem Participants7 items

Data Providers — Supply genomic datasets for blockchain validation and storage

Blockchain Technology Providers — Develop distributed ledger frameworks for genomic data security

System Integrators — Implement blockchain solutions with laboratory information systems

Platform Operators — Manage decentralized networks for data sharing and analytics

Service Providers — Offer encryption, consent management, and audit trail functionalities

End Users — Include research institutions, hospitals, and biopharma firms utilizing genomic data

Regulatory Bodies — Establish standards for data privacy, compliance, and cross-border interoperability

Control points reside in data access governance, regulatory certification, and platform integration capabilities. Bottlenecks emerge from fragmented standards and data ownership disputes. Long-term adoption depends on partnerships addressing interoperability, while switching costs are influenced by platform lock-in from proprietary encryption protocols.

Recent Industry Insights

The Genomics Blockchain industry trends over the past 12–18 months have been shaped by strategic collaborations, technological advancements, and evolving regulatory frameworks. Key players have prioritized partnerships to integrate blockchain with genomic data management, such as Nebula Genomics collaborating with blockchain platforms to enhance data privacy and consent control. Mergers & acquisitions have also accelerated, with firms like DNAChain acquiring smaller bioinformatics startups to expand their decentralized analytics capabilities. On the innovation front, product/technology launches include AI-driven blockchain solutions for secure genomic data sharing, exemplified by Chronobank’s GenomiX platform. Regulatory shifts, particularly in the EU and U.S., have emphasized stricter compliance for genetic data handling, pushing companies to adopt auditable blockchain systems. Enterprise demand has surged for transparent, tamper-proof genomics solutions, driven by rising consumer awareness around data ownership. Notably, funding rounds have seen a 30% increase since 2023, with startups like EncrypGen securing Series A investments to scale decentralized genomic marketplaces. These developments underscore a maturing market poised for adoption as interoperability and regulatory clarity improve.

Analyst Overview

The Genomics Blockchain market outlook remains highly attractive, driven by escalating demand for secure, decentralized genomic data management. With advancements in personalized medicine and precision healthcare, blockchain's role in ensuring data integrity and privacy is critical. The market's attractiveness is further bolstered by regulatory tailwinds and growing biopharma investments in data-driven R&D.

Competitive intensity is moderate, with a mix of niche blockchain developers and established genomics firms vying for technical differentiation. While collaboration is emerging to address interoperability challenges, the innovation landscape is robust, with patents focusing on smart contracts for consent management and AI-integrated genomic analytics.

The demand–supply balance favors demand, as current infrastructure struggles to scale with the exponential growth of genomic datasets. However, long-term outlook is optimistic, projecting a 2030 inflection point with maturation of 5G and quantum-resistant blockchain protocols. Key risk factors include fragmented regulatory frameworks and ethical dilemmas around data ownership, necessitating proactive governance models.

11 items

1. Executive Summary

2. Genomics Blockchain Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Genomics Blockchain Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Genomics Blockchain Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Pharmaceuticals and Biotechnology

6.1.3. Research Institute

6.1.4. Others

6.2. Global Genomics Blockchain Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Business to Customer (B2C)

6.2.2. Business to Business (B2B)

6.2.3. Customer to Business (C2B)

6.3. Global Genomics Blockchain Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Genomics Blockchain Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Genomics Blockchain Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Genomics Blockchain Market Competition by Key Manufacturers

8.1. Global Genomics Blockchain Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Genomics Blockchain: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Nebula Genomics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. SimplyVital Health

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. LunaDNA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Encrypgen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Digital DNAtix

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Longenesis

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shivom Ventures

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Genobank.io

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Genomes.io

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Zenome.io

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. WuXi Nextcode Genomics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. MGI Tech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Genomics Blockchain Market

Figure 4: Global Genomics Blockchain Market: Drivers

Figure 5: Global Genomics Blockchain Market: Challenges

Figure 6: Global Genomics Blockchain Market: Trends

Figure 7: Global Genomics Blockchain Market: Opportunity

Figure 8: Global Genomics Blockchain Market: Restraint

Figure 9: Global Genomics Blockchain Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Genomics Blockchain Market Value (USD Million) By Region

Figure 15: Global Genomics Blockchain Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Genomics Blockchain Market Value (USD Million) By Region

Figure 23: Global Genomics Blockchain Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Genomics Blockchain Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Genomics Blockchain Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Genomics Blockchain Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Genomics Blockchain Market Value (USD Million) By Region

Table 10: Global Genomics Blockchain Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Genomics Blockchain Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Genomics Blockchain Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Genomics Blockchain Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Nebula Genomics Basic Information And Sales Area

Table 31: Nebula Genomics. Products Portfolio

Table 32: SimplyVital Health Basic Information And Sales Area

Table 33: SimplyVital Health. Products Portfolio

Table 34: LunaDNA Basic Information And Sales Area

Table 35: LunaDNA. Products Portfolio

Table 36: Encrypgen Basic Information And Sales Area

Table 37: Encrypgen. Products Portfolio

Table 38: Digital DNAtix Basic Information And Sales Area

Table 39: Digital DNAtix. Products Portfolio

Table 40: Longenesis Basic Information And Sales Area

Table 41: Longenesis. Products Portfolio

Table 42: Shivom Ventures Basic Information And Sales Area

Table 43: Shivom Ventures. Products Portfolio

Table 44: Genobank.io Basic Information And Sales Area

Table 45: Genobank.io. Products Portfolio

Table 46: Genomes.io Basic Information And Sales Area

Table 47: Genomes.io. Products Portfolio

Table 48: Zenome.io Basic Information And Sales Area

Table 49: Zenome.io. Products Portfolio

Table 50: WuXi Nextcode Genomics Basic Information And Sales Area

Table 51: WuXi Nextcode Genomics. Products Portfolio

Table 52: MGI Tech Basic Information And Sales Area

Table 53: MGI Tech. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Genomics Blockchain Market Value (USD Million) By Region

Table 59: Global Genomics Blockchain Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Genomics Blockchain Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	3.57 billion
Growth rate	CAGR of 35.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nebula Genomics; SimplyVital Health; LunaDNA; Encrypgen; Digital DNAtix; Longenesis; Shivom Ventures; Genobank.io; Genomes.io; Zenome.io; WuXi Nextcode Genomics; MGI Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Genomics Blockchain Segmentation Breakdown9 items

Application

Hospital

Pharmaceuticals and Biotechnology

Research Institute

Others

Types

Business to Customer (B2C)

Business to Business (B2B)

Customer to Business (C2B)

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: High adoption of precision medicine, strong policy frameworks, and cross-industry investments in genomic data security.

Europe: Stringent data privacy regulations (GDPR), collaborative research ecosystems, and public-private partnerships in genomic sequencing.

Asia Pacific: Rapid infrastructure development, growing demographic demand, and government policies promoting blockchain in healthcare.

Latin America: Increasing cross-border collaborations and digital health adoption, though lagging in ecosystem maturity.

Middle East & Africa: Emerging regulatory frameworks and strategic partnerships to address genomic data gaps in underserved populations.

Competitive Landscape

Nebula Genomics: Expanding product line with AI-driven genomic analysis tools

SimplyVital Health: Strengthening partnerships with pharma firms for data access

LunaDNA: Focusing on decentralized data ownership and user-centric models

Encrypgen: Prioritizing blockchain-based genomic data marketplaces

Digital DNAtix: Launching enterprise-grade encryption solutions for healthcare

Longenesis: Investing in AI-enabled genomics analytics for precision medicine

Key Genomics Blockchain Companies12 items

Nebula Genomics

SimplyVital Health

LunaDNA

Encrypgen

Digital DNAtix

Longenesis

Shivom Ventures

Genobank.io

Genomes.io

Zenome.io

WuXi Nextcode Genomics

MGI Tech

Market Ecosystem

Ecosystem Participants7 items

Data Providers — Supply genomic datasets for blockchain validation and storage

Blockchain Technology Providers — Develop distributed ledger frameworks for genomic data security

System Integrators — Implement blockchain solutions with laboratory information systems

Platform Operators — Manage decentralized networks for data sharing and analytics

Service Providers — Offer encryption, consent management, and audit trail functionalities

End Users — Include research institutions, hospitals, and biopharma firms utilizing genomic data

Regulatory Bodies — Establish standards for data privacy, compliance, and cross-border interoperability

Recent Industry Insights

Analyst Overview

Table of Contents